Molecular targets in idiopathic pulmonary fibrosis

Respiration and Circulation

Volumn 58, Issue 10, 2010, Pages 979-985

  Kuwano, Kazuyoshi ^a   Araya, Jun ^a   Hara, Hiromichi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FIBROSING ALVEOLITIS; MOLECULARLY TARGETED THERAPY;

EID: 78049331405     PISSN: 04523458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 165 : 277-304, 2002
2. Kuwano K, Miyazaki H, Hagimoto N, et al : The involvement of Fas-Fas ligand pathway in fibrosing lung diseases. Am J Respir Cell Mol Biol 20 : 53-60, 1999 (Pubitemid 129504842)
3. Hagimoto N, Kuwano K, Inoshima I, et al : TGF-β1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J Immunol 168 : 6470-6478, 2002 (Pubitemid 34620072)
4. Wang R, Ramos C, Joshi I, et al : Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides. Am J Physiol 277 : L1158-L1164, 1999
5. Raghu G, Weycker D, Edelsberg J, et al : Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174 : 810-816, 2006
6. Alder JK, Chen JJ, Lancaster L, et al : Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 105 : 13051-13056, 2008
7. Cronkhite JT, Xing C, Raghu G, et al : Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med 178 : 729-737, 2008
8. Kubo H, Nakayama K, Yanai M, et al : Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest 128 : 1475-1482, 2005 (Pubitemid 41324435)
9. Raghu G, Brown KK, Costabel U, et al : Treatment of idiopathic pulmonary fibrosis with etanercept : an exploratory, placebo-controlled trial. Am J Respir Crit Care Med 178 : 948-955, 2008
10. Antoniades HN, Neville-Golden J, Galanopoulos T, et al : Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 89 : 5371-5375, 1992
11. Suga M, Iyonaga K, Ichiyasu H, et al : Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Eur Respir J 14 : 376-382, 1999
12. Daniels CE, Lasky JA, Limper AH, et al : Imatinib treatment for idiopathic pulmonary fibrosis : randomized placebo-controlled trial results. Am J Respir Crit Care Med 181 : 604-610, 2010
13. Raghu G, Brown KK, Bradford WZ, et al : A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 350 : 125-133, 2004
14. King TE Jr, Albera C, Bradford WZ, et al : Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE) : a multicentre, randomised, placebo-controlled trial. Lancet 374 : 222-228, 2009
15. Azuma A, Nukiwa T, Tsuboi E, et al : Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 171 : 1040-1047, 2005
16. Taniguchi H, Ebina M, Kondoh Y, et al : Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 35 : 821-829, 2010
17. Klingsberg RC, Mutsaers SE, Lasky JA : Current clinical trials for the treatment of idiopathic pulmonary fibrosis. Respirology 15 : 19-31, 2010
18. Charbeneau RP, Peters-Golden M : Eicosanoids : mediators and therapeutic targets in fibrotic lung disease. Clin Sci(Lond) 108 : 479-491, 2005
19. King TE Jr, Behr J, Brown KK, et al : Am J Respir Crit Care Med 177 : 75-81, 2008
20. Collard HR, Anstrom KJ, Schwarz MI, et al : Sildenafil improves walk distance in idiopathic pulmonary fibrosis. Chest 131 : 897-899, 2007 (Pubitemid 46446887)
21. Jackson RM, Glassberg MK, Ramos CF, et al : Sildenafil therapy and exercise tolerance in idiopathic pulmonary fibrosis. Lung 188 : 115-123, 2010
22. Zisman DA, Schwarz MI, Anstrom KJ, et al : A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med 2010, in press
23. Kuwano K, Nakashima N, Inoshima I, et al : Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias. Eur Respir J 21 : 232-240, 2003
24. Demedts M, Behr J, Buhl R, et al : High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353 : 2229-2242, 2005
25. Hamada N, Kuwano K, Yamada M, et al : Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice. J Immunol 175 : 1224-1231, 2005